日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted (212)Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer

AB001(一种靶向前列腺特异性膜抗原的(212)Pb放射性配体)在转移性去势抵抗性前列腺癌患者中的首次人体0期研究

Berner, Kjetil; Hernes, Eivor; Kvassheim, Monika; Revheim, Mona-Elisabeth; Bastiansen, Julie; Selboe, Silje; Bakken, Charlotte L; Grønningsæter, Simen R; Bruland, Øyvind S; Larsen, Roy H; Bouzelmat, Lily; Jardine, Vicki L; Stokke, Caroline

First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)

首次在结直肠癌腹膜转移的 CRS-HIPEC 治疗中使用 (224)镭标记微粒 (Radspherin®)(一项 1 期研究)

Larsen, Stein Gunnar; Graf, Wilhelm; Mariathasan, Anthony Burton; Sørensen, Olaf; Spasojevic, Milan; Goscinski, Mariusz Adam; Selboe, Silje; Lundstrøm, Nadja; Holtermann, Anne; Revheim, Mona-Elisabeth; Bruland, Øyvind Sverre

Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis

腹膜转移患者使用镭-224-碳酸钙微粒的辐射安全考虑

Simen Rykkje Grønningsæter, Johan Blakkisrud, Silje Selboe, Mona-Elisabeth Revheim, Øyvind Sverre Bruland, Tina Bjørnlund Bønsdorff, Stein Gunnar Larsen, Caroline Stokke